A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TRL / triglyceride-rich lipoproteins

[Related PubMed/MEDLINE]
Total Number of Papers: 263
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TRL  (>> Co-occurring Abbreviation)
Long Form:   triglyceride-rich lipoproteins
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A single bout of resistance exercise improves postprandial lipid metabolism in overweight/obese men with prediabetes. TG
2020 Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia. HDL, HTG, LCF, TG, VLDL
2020 Clinical review on triglycerides. ---
2020 Effect of fasting and feeding on apolipoprotein A-I kinetics in prebeta1-HDL, alpha-HDL, and triglyceride-rich lipoproteins. apo, HDL, VLDL
2020 Exopolysaccharides from milk fermented by lactic acid bacteria enhance dietary carotenoid bioavailability in humans in a randomized crossover trial and in rats. AUC, EPS, iAUC
2020 Lipoprotein insulin resistance score and branched-chain amino acids increase after adrenalectomy for unilateral aldosterone-producing adenoma: a preliminary study. APA, BCAA, LPIR, NMR, PA
2020 Postprandial dyslipidemia in insulin resistant states in adolescent populations. CMs, CVD, HDL-C, LDL-C
2020 Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers. apoB, CVD, HTG, LDL, non-HDL-C, TG
2020 Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease. CI, CVD, HR, IS, MI, PAD, sdLDL, sdLDL-C, TRL-C
10  2020 Triglycerides and residual risk. CV risk, EPA, PCSK9, REDUCE-IT, VITAL
11  2019 ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors. LDLR, LRP1
12  2019 Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD. apoC-III, LOF, LPL
13  2019 Mamey sapote fruit and carotenoid formulations derived thereof are dietary sources of vitamin A - A comparative randomized cross-over study. ---
14  2019 Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State. ANGPTL3, LDL, LOF, VLDL
15  2019 Moving Targets: Recent Advances in Lipid-Lowering Therapies LDL-C
16  2019 Novel lipoprotein density profiling in laminitic, obese, and healthy horses. CLPDP, HDLs, LDLs
17  2019 Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker. apo, apoA-I, BCAA, HDL-C, LDL-C, NMR, PA, TG
18  2019 The Effect of an Iron Supplement on Lycopene Metabolism and Absorption During Digestion in Healthy Humans. LYC
19  2018 Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet. AnxA6, HDL, HFD, KO, WT
20  2018 Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism. apo
21  2018 Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis. ANGPTL4, AT, BAT, FA, LPL
22  2018 Differential associations between plasma concentrations of insulin and glucose and intestinal expression of key genes involved in chylomicron metabolism. apo, IR
23  2018 Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal Women. apo, FCR, IDL, LDL, PR
24  2018 Lipoprotein lipase transporter GPIHBP1 and triglyceride-rich lipoprotein metabolism. CVD, GPIHBP1, LPL
25  2018 New medications targeting triglyceride-rich lipoproteins: Can inhibition of ANGPTL3 or apoC-III reduce the residual cardiovascular risk? ANGPTL3, apoC-III, CVD, FH
26  2018 Production of asymmetric oxidative metabolites of [13C]-beta-carotene during digestion in the gastrointestinal lumen of healthy men. ---
27  2018 The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins. ICD, LDL, LRP1, PID1
28  2017 A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels. A43T, CHD, LDL-C, TG
29  2017 ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans. hyperTG, IR, WAT
30  2017 ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen. apoC-III, CHD, LPL, TG
31  2017 Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism. apoC-II, CM, HDL, HTG, LPL, TG, VLDL
32  2017 Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men. ---
33  2017 Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects. apoC-III, HDL-C, TGs
34  2017 Indispensable role of lipoprotein bound-ApoE in adipogenesis and endocytosis induced by postprandial TRL. APOE, h-TRL, RAP
35  2016 Alterations in triglyceride rich lipoproteins are related to endothelial dysfunction in metabolic syndrome. MetS
36  2016 Deregulated Lipid Sensing by Intestinal CD36 in Diet-Induced Hyperinsulinemic Obese Mouse Model. HFD, MetS, TG
37  2016 Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men. GIP, GLP, OGTT, TG
38  2016 New Therapeutic Approaches to the Treatment of Dyslipidemia. ASCVD, HDL, LDL
39  2016 Remnant lipoprotein size distribution profiling via dynamic light scattering analysis. CVD, RLP
40  2016 Role of sulfatase 2 in lipoprotein metabolism and angiogenesis. HSPG, SULF2
41  2016 Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III. apo, FCR, PR, VLDL
42  2016 [Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update]. CETP, HDL-C, LDL-C, PCSK9
43  2015 Dysfunction of lipid metabolism in lipodystrophic Seipin-deficient mice. CGL, VLDL
44  2015 Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update. CVD, LDL, PUFA, VLDL
45  2015 Effects of egg consumption on carotenoid absorption from co-consumed, raw vegetables. AUCs, HE, LE
46  2015 Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients. ESRD, HDL, IDL
47  2015 Identification of molecular species of oxidized triglyceride in plasma and its distribution in lipoproteins. HDL, HPLC, IDL, TGOOH, VLDL
48  2015 Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state. apo, AUC, CV, FCRs, HOMA, LPL, PCSK9
49  2015 Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia. apoB, FCR, FHBL, IDL, LDL, VLDL
50  2015 Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. ---
51  2015 Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals inHungary. ---
52  2015 PCSK9 and triglyceride-rich lipoprotein metabolism. LDL, LDLR, PCSK9, TG
53  2014 Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men. apo, MCT, VLDL
54  2014 Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial. LCn3s, VLDLs
55  2014 Effect of sitagliptin therapy on triglyceride-rich lipoprotein kinetics in patients with type 2 diabetes. apo
56  2014 Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans. ---
57  2014 Glucagon-like peptide-2 regulates release of chylomicrons from the intestine. GLP-2
58  2014 Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins. apo, DNL
59  2014 Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. CV, FFA, HDL, LDL, MS, T2DM, TG, VLDL
60  2014 New and emerging regulators of intestinal lipoprotein secretion. FFA
61  2014 Postprandial enrichment of triacylglycerol-rich lipoproteins with omega-3 fatty acids: lack of an interaction with apolipoprotein E genotype? apo, DHA, EPA, FA
62  2014 Triglyceride-rich lipoproteins and cytosolic lipid droplets in enterocytes: key players in intestinal physiology and metabolic disorders. LDs
63  2013 Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. HSPG, SDC1
64  2013 Comparison of high-performance liquid chromatography/tandem mass spectrometry and high-performance liquid chromatography/photo-diode array detection for the quantitation of carotenoids, retinyl esters, alpha-tocopherol and phylloquinone in chylomicron-rich fractions of human plasma. APCI, HPLC-PDA
65  2013 Demystifying the management of hypertriglyceridaemia. apo, CVD
66  2013 Dietary fatty acids and lipoprotein metabolism: new insights and updates. CVD, PUFA
67  2013 Exercise prevents fructose-induced hypertriglyceridemia in healthy young subjects. apo
68  2013 Lipids and HCV. apoB, APOE, HCV, LDL, LVP, VLDL
69  2013 Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue. WAT
70  2013 Postprandial lipoproteins and the molecular regulation of vascular homeostasis. ---
71  2013 Postprandial triglyceridemia after single dose of alcohol in healthy young men. HTGL, IDL, LPL, TG
72  2013 The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/macrophage cells. ApoB48R, MUFA, ROO, SFA
73  2013 Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice. BSCL, MEFs
74  2012 Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat. apoB-48, FFA, FGF21, TG, VLDL1
75  2012 Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism. CETP, PR, PS
76  2012 Effects of rs7903146 variation in the Tcf7l2 gene in the lipid metabolism of three different populations. MetS, SNP, TG
77  2012 Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects. TLC
78  2012 Low density lipoprotein receptor-related protein 1 dependent endosomal trapping and recycling of apolipoprotein E. APOE, HDL, LDL, LRP1
79  2012 Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography. FFA, MS
80  2012 Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels. APOE, CTRL, LPL, NS
81  2012 White adipose tissue apolipoprotein C-I secretion in relation to delayed plasma clearance of dietary fat in humans. apo, WAT
82  2011 Acute hypertriglyceridemia promotes intestinal lymphatic lipid and drug transport: a positive feedback mechanism in lipid and drug absorption. CM, MetS
83  2011 Consumption of diets with different type of fat influences triacylglycerols-rich lipoproteins particle number and size during the postprandial state. CHO, MUFA, PUFA, SFA, TG
84  2011 Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters. CETP, HDL, RCT
85  2011 Gut-liver interaction in triglyceride-rich lipoprotein metabolism. ---
86  2011 Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry. HCV, LPL, VLDL
87  2011 Lycopene bioavailability and metabolism in humans: an accelerator mass spectrometry study. ---
88  2011 Postprandial lipemia in the elderly involves increased incorporation of ingested fat in plasma free fatty acids and small (Sf 20-400) triglyceride-rich lipoproteins. FFAs, TG
89  2010 Adjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteins. CVD, HDL-C, LDL-C, TG
90  2010 Cell-mediated lipoprotein transport: a novel anti-atherogenic concept. CR1
91  2010 Delayed postprandial metabolism of triglyceride-rich lipoproteins in obese young men compared to lean young men. HOMA-IR, RLP-C, TG
92  2010 Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles. HCV
93  2010 Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: implications for dementia risk. apoB, SFA
94  2010 The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. ApoB-48, DPP-4, GLP-1
95  2010 Vitamin A equivalence of the ss-carotene in ss-carotene-biofortified maize porridge consumed by women. ---
96  2009 Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia. apo, FCR, PR, PS
97  2009 Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. apoB, HCV, LVP
98  2009 Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1. PPM, TG
99  2009 The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients. AUCs
100  2008 Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. apo, FFA